• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Argentina Healthcare, Regulatory and Reimbursement Landscape
 

Argentina Healthcare, Regulatory and Reimbursement Landscape

on

  • 277 views

Buy the report "Healthcare, Regulatory and Reimbursement Landscape – Argentina" at US $1995 for a Single User PDF License from RnR Market Research Reports Library.Industry analysis specialist ...

Buy the report "Healthcare, Regulatory and Reimbursement Landscape – Argentina" at US $1995 for a Single User PDF License from RnR Market Research Reports Library.Industry analysis specialist GlobalData has released its latest report “Healthcare, Regulatory and Reimbursement Landscape – Argentina”.

Statistics

Views

Total Views
277
Views on SlideShare
277
Embed Views
0

Actions

Likes
0
Downloads
4
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Argentina Healthcare, Regulatory and Reimbursement Landscape Argentina Healthcare, Regulatory and Reimbursement Landscape Document Transcript

    • RnR Market Research Offers “Healthcare, Regulatory and Reimbursement Landscape –Argentina” Report at US$ 1995 Single User License. The report got published in Apr 2013Contain 155 Pages.Value of Argentina’s Pharmaceutical Market to Almost Triple in Value over One Decade, Says GlobalDataAnalysisArgentina’s pharmaceutical market is expected to grow from a value of around US$5.6 billion in 2012 toUS$15 billion by 2020, thanks to a strong presence of domestic laboratories, high-quality manufacturingcapabilities and favorable clinical trial regulations, cites new analysis by research and consulting firmGlobalData.According to the new report*, domestic laboratories account for over 50% of the Argentinepharmaceutical market. Key domestic companies include Roemmers and Bagó, while multinationals suchas Bayer, Novartis, Roche, Abbott and GlaxoSmithkline (GSK) also operate in the country.The trend towards domestic pharma production has existed for several decades in Argentina. Localplayers are provided with government benefits such as favorable tariff protection, while raw materialimport costs historically undercut the transfer pricing generally applicable for multinationals. This givesdomestic players a competitive advantage in Argentina.The Argentine government enacted a law as part of the Health Emergency Act, enforcing physicians toinclude generic names of prescribed products, enabling pharmacies to use generic substitution. Theresultant increase in generic sales led to the growth of Argentine generic drug manufacturers.Get Report Details @ http://www.rnrmarketresearch.com/healthcare-regulatory-and-reimbursement-landscape-argentina-market-report.htmlArgentina’s regulations governing intellectual property rights have also historically provided a distinctadvantage to domestic companies, who were free to manufacture and sell products similar to patentedversions. However, since Argentina became a signatory of Trade Related Intellectual Property rights(TRIPS) and General Agreement on Tariffs and Trade (GATT), local manufacturers could be negativelyaffected by restrictions on the manufacture and sale of patented products.Argentina is also considered a favorable destination for cost-effective clinical trials within the LatinAmerican region, and was one of the first Latin American countries to implement the recommendations ofthe WHO’s Good Manufacturing Practices and Control standards, endorsing compliance to aninternational set of quality standards for pharmaceutical production. Clinical trial standards are alsosimilar to the International Conference on Harmonization – Good Clinical Practice (ICH-GCP) standards.However, Argentina’s pharmaceutical industry faces some barriers. Argentine pharmaceutical companieslack the vast production capacities of Chinese and Indian companies, and are unable to compete withlower prices offered by them. Argentina also faces stiff challenges from other Latin American countriessuch as Mexico and Brazil, who have strengthened their pharmaceutical industries over the last decade.In addition, the research and development (R&D) efforts of domestic pharmaceutical companies do nothold a fruitful history, and although investment has increased over the past few years, no local playershave been able to develop new chemical entities, making it difficult for domestic companies to competewith innovative multinationals.
    • The Argentine medical devices market is predicted to grow at a more modest rate, from approximatelyUS$1.7 billion in 2012 to US$2.4 billion in 2020.*Healthcare, Regulatory and Reimbursement Landscape – ArgentinaThis report provides an essential source of information and analysis on the Argentina’s healthcare,regulatory and reimbursement landscape, identifying key trends in the market and providing insights intothe demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Mostimportantly, the report provides valuable insights into the trends and segmentation of the pharmaceuticaland medical device markets.This report was built using data and information sourced from proprietary databases, primary andsecondary research, and in-house analysis conducted by GlobalData’s team of industry experts.Buy a Report Copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=91738Reasons to buyThe report will enhance your decision-making capability and allow you to -- Develop business strategies by understanding the trends shaping and driving the healthcare market- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceuticaland medical devices market segments and companies likely to impact the healthcare market in the future- Formulate effective sales and marketing strategies by understanding the competitive landscape andanalyzing the performance of various competitors- Organize your sales and marketing efforts by identifying the market categories and segments thatpresent the most opportunities for consolidation, investment and strategic partnerships- Identify, understand and capitalize on the opportunities and challenges in the healthcare marketTable of Content1 Table of Contents 51.1 List of Tables 71.2 List of Figures 82 Introduction 102.1 GlobalData Report Guidance 103 Overview of Pharmaceutical and Medical Device Market 113.1 Pharmaceutical Market 113.1.1 Market Overview 113.1.2 Supply Channels 143.1.3 Market Segments 153.1.4 Overview of Major Therapeutic Areas 193.1.5 Major Players 273.2 Medical Device Market 473.2.1 Market Overview 473.2.2 Overview of Top Five Segments 493.2.3 Diagnostic Market 653.2.4 Major Players 673.3 Market Drivers and Barriers 893.3.1 Drivers 893.3.2 Barriers 904 Market Access 91
    • 4.1 Reimbursement and Payer Landscape 914.1.1 Overview of Healthcare System 914.1.2 Reimbursement Process 944.1.3 Patient Share in Healthcare Spending 954.1.4 Pricing Policies 964.2 Regulatory Landscape 964.2.1 Overview of Regulatory Agencies 964.2.2 Market Authorization Procedure for Pharmaceutical Products 974.2.3 New Medical Device Approval Process 984.2.4 Exports and Imports 984.2.5 Intellectual Property Rights 994.2.6 Clinical Trial Regulations 1024.2.7 Pharmaceutical Advertising Regulations 1034.2.8 Pharmacy Regulations 1034.2.9 Prescription by Active Ingredient Name 1034.2.10 Labeling and Packaging Regulations 1045 Country Analysis 1055.1 Political Environment 1055.1.1 Political Structure 1055.1.2 Analysis of Current Political Environment 1055.1.3 Healthcare Policy Initiatives 1065.2 Economic Landscape 1065.3 Economic Indicators 1075.3.1 Gross Domestic Product 1075.3.2 Gross National Income 1105.3.3 Inflation 1115.3.4 Currency Exchange Rate 1145.3.5 Foreign Direct Investment 1155.3.6 Foreign Exchange Reserves 1165.3.7 Trade Balance 1175.3.8 General Government Structural Balance 1195.3.9 General Government Gross Debt 1205.3.10 Major Industries 1205.4 Demographics 1215.4.1 Population 1215.4.2 Education and Literacy 1365.4.3 Employment 1375.4.4 Disease Burden 1385.5 Healthcare Infrastructure 1405.5.1 Healthcare Facilities 1405.5.2 Healthcare Parameters 1415.5.3 Environmental Health 1415.5.4 Healthcare Personnel 1435.6 Healthcare Expenditure 1445.6.1 Overview 1445.6.2 Share of Public and Private Sector 1455.7 Trade Associations 1465.7.1 Argentina Association of Hospital Pharmacists 1465.7.2 Industrial Chamber of Argentine Pharmaceutical Laboratories 1465.7.3 Association of Medical Specialties Distributors 1465.8 Trade Fairs 1466 Opportunities and Challenges 147
    • 6.1 Opportunities 1476.2 Challenges 1477 Appendix 1497.1 Abbreviations 1497.2 Bibliography 1517.3 Methodology 1547.3.1 Coverage 1547.3.2 Secondary Research 1547.3.3 Forecasting 1557.3.4 Expert Panel Validation 1557.4 Contact Us 1557.5 Disclaimer 155For more details contact Mr. Priyank Tiwari: sales@rnrmarketresearch.com / +18883915441Website: http://www.rnrmarketresearch.com